Trial identifies breast cancer patients likely to benefit from experimental drug

[News]

In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed...

More... (http://www.medicalnewstoday.com/releases/275251.php)